Skip to main content
Erschienen in: Inflammation Research 5/2015

01.05.2015 | Original Research Paper

Association of systemic inflammation with epicardial fat and coronary artery calcification

verfasst von: Sören Gauss, Lutz Klinghammer, Alina Steinhoff, Dorette Raaz-Schrauder, Mohamed Marwan, Stephan Achenbach, Christoph D. Garlichs

Erschienen in: Inflammation Research | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Increased epicardial fat volume (EFV) has been shown to be associated with coronary atherosclerosis. While it is postulated to be an independent risk factor, a possible mechanism is local or systemic inflammation. We analyzed the relationship between coronary atherosclerosis, quantified by coronary calcium in CT, epicardial fat volume and systemic inflammation.

Methods

Using non-enhanced dual-source CT, we quantified epicardial fat volume (EFV) and coronary artery calcium (CAC) in 391 patients who underwent coronary computed tomography for suspected coronary artery disease. In addition to traditional risk factors, serum markers of systemic inflammation were measured (IL-1α, IL-2, IL-4, IL-6, IL-7, IL-8, IL-10,IL-12, IL-13, IL-15, IL-17, IFN-γ, TNF-α, hs-CRP, GM-CS, G-CSF, MCP-1, MIP-1, Eotaxin and IP-10). In 94 patients follow-up data were obtained after 1.9 ± 0.5 years.

Results

The 391 patients had a mean age of 60 ± 10 years, and 69 % were males. Mean EFV was 116 ± 50 mL. Median CAC was 12 (IQR 0; 152). CAC and EFV showed a significant correlation (ρ = 0.37; P < 0.001). EFV and CAC were significantly correlated with the traditional risk factors like age, male gender, diabetes, smoking and hypertension. With regard to biomarkers, CAC was significantly associated (negatively) to G-CSF and IL-13. EFV (median binned) was significantly associated (positively) with IP-10 (P = 0.002) and MCP-1 (ρ = 0.037). In follow-up, EFV showed a mean annualized progression of 6 mL (IQR 3; 9) (P < 0.001); CAC progressed by a mean of six Agatston Units (IQR 0; 30). The progression of CAC was significantly correlated with the extent of EFV (P < 0.001) while there was no significant correlation between progression of EFV or CAC with systemic inflammation markers.

Conclusion

Epicardial fat volume and the baseline extent as well as progression of coronary atherosclerosis—measured by the calcium score—are significantly correlated. While both baseline EFV and CAC displayed significant correlations with systemic inflammation markers, biomarkers were not predictive of the progression of CAC or EFV.
Literatur
2.
Zurück zum Zitat Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Carr JJ, Rich SS, et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J. 2006;151:706–11.CrossRefPubMed Burdon KP, Langefeld CD, Beck SR, Wagenknecht LE, Carr JJ, Rich SS, et al. Variants of the CD40 gene but not of the CD40L gene are associated with coronary artery calcification in the Diabetes Heart Study (DHS). Am Heart J. 2006;151:706–11.CrossRefPubMed
3.
Zurück zum Zitat Oei HH, Sayed-Tabatabaei FA, Hofmann A, Oudkerk M, van Duijn CM, Witteman JC. The association between angiotensin-converting enzyme gene polymorphism and coronary calcification: the Rotterdam Coronary Calcification Study. Atherosclerosis. 2005;182:169–73.CrossRefPubMed Oei HH, Sayed-Tabatabaei FA, Hofmann A, Oudkerk M, van Duijn CM, Witteman JC. The association between angiotensin-converting enzyme gene polymorphism and coronary calcification: the Rotterdam Coronary Calcification Study. Atherosclerosis. 2005;182:169–73.CrossRefPubMed
4.
Zurück zum Zitat Reilly MP, Wolfe ML, Dykhouse J, Reddy K, Localio AR, Rader DJ. Intercellular adhesion molecule 1 (ICAM-1) gene variant is associated with coronary artery calcification independent of soluble ICAM-1 levels. J Investig Med. 2004;52:515–22.PubMed Reilly MP, Wolfe ML, Dykhouse J, Reddy K, Localio AR, Rader DJ. Intercellular adhesion molecule 1 (ICAM-1) gene variant is associated with coronary artery calcification independent of soluble ICAM-1 levels. J Investig Med. 2004;52:515–22.PubMed
5.
Zurück zum Zitat Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation. 2006;113:38–43.CrossRefPubMed Khera A, de Lemos JA, Peshock RM, Lo HS, Stanek HG, Murphy SA, et al. Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study. Circulation. 2006;113:38–43.CrossRefPubMed
6.
Zurück zum Zitat Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation. 2002;106:1189–91.CrossRefPubMed Wang TJ, Larson MG, Levy D, Benjamin EJ, Kupka MJ, Manning WJ, et al. C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study. Circulation. 2002;106:1189–91.CrossRefPubMed
7.
Zurück zum Zitat Raaz-Schrauder D, Klinghammer L, Baum C, Frank T, Lewczuk P, Achenbach S, et al. Association of systemic inflammation markers with the presence and extent of coronary artery calcification. Cytokine. 2012;57:251–7.CrossRefPubMed Raaz-Schrauder D, Klinghammer L, Baum C, Frank T, Lewczuk P, Achenbach S, et al. Association of systemic inflammation markers with the presence and extent of coronary artery calcification. Cytokine. 2012;57:251–7.CrossRefPubMed
8.
Zurück zum Zitat Tadros TM, Massaro JM, Rosito GA, Hoffmann U, Vasan RS, Larson MG, et al. Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity. 2010;18:1039–44.CrossRefPubMedCentralPubMed Tadros TM, Massaro JM, Rosito GA, Hoffmann U, Vasan RS, Larson MG, et al. Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study. Obesity. 2010;18:1039–44.CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J. 2011;52:139–42.CrossRefPubMed Hirata Y, Kurobe H, Akaike M, Chikugo F, Hori T, Bando Y, et al. Enhanced inflammation in epicardial fat in patients with coronary artery disease. Int Heart J. 2011;52:139–42.CrossRefPubMed
10.
Zurück zum Zitat Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses apathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.CrossRefPubMedCentralPubMed Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, et al. Human epicardial adipose tissue expresses apathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006;5:1.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, et al. Association among plasma levels of monocyte chemoattractant protein 1, traditional cardiovascular risk factors and subclinical atherosclerosis. J Am Coll Cardiol. 2004;44:1812–8.CrossRefPubMed Deo R, Khera A, McGuire DK, Murphy SA, Meo Neto Jde P, Morrow DA, et al. Association among plasma levels of monocyte chemoattractant protein 1, traditional cardiovascular risk factors and subclinical atherosclerosis. J Am Coll Cardiol. 2004;44:1812–8.CrossRefPubMed
12.
Zurück zum Zitat Konishi M, Sugiyama S, Sato Y, Oshima S, Sugamura K, Nozaki T, et al. Pericardial fat inflammation correlates with coronary artery disease. Atherosclerosis. 2010;213:649–55.CrossRefPubMed Konishi M, Sugiyama S, Sato Y, Oshima S, Sugamura K, Nozaki T, et al. Pericardial fat inflammation correlates with coronary artery disease. Atherosclerosis. 2010;213:649–55.CrossRefPubMed
13.
Zurück zum Zitat Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metabo Res. 2008;40:442–5.CrossRef Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as pro- and anti-inflammatory organ. Horm Metabo Res. 2008;40:442–5.CrossRef
14.
Zurück zum Zitat Iacobellis G, Pistilli D, Gucciardo M. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29:251–5.PubMed Iacobellis G, Pistilli D, Gucciardo M. Adiponectin expression in human epicardial adipose tissue in vivo is lower in patients with coronary artery disease. Cytokine. 2005;29:251–5.PubMed
15.
Zurück zum Zitat Mazurek T, Zhang L, Zalewski A. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.CrossRefPubMed Mazurek T, Zhang L, Zalewski A. Human epicardial adipose tissue is a source of inflammatory mediators. Circulation. 2003;108:2460–6.CrossRefPubMed
16.
Zurück zum Zitat Kremen J, Dolinkova M, Krajickova J. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab. 2006;91:4620–7.CrossRefPubMed Kremen J, Dolinkova M, Krajickova J. Increased subcutaneous and epicardial adipose tissue production of proinflammatory cytokines in cardiac surgery patients: possible role in postoperative insulin resistance. J Clin Endocrinol Metab. 2006;91:4620–7.CrossRefPubMed
17.
Zurück zum Zitat Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536–43.CrossRefPubMed Iacobellis G, Corradi D, Sharma AM. Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005;2:536–43.CrossRefPubMed
18.
Zurück zum Zitat Iacobellis G, Pond CM, Sharma AM. Different “weight” of cardiac and general adiposity in predicting left ventricle morphology. Obesity. 2006;14:1679–84.CrossRefPubMed Iacobellis G, Pond CM, Sharma AM. Different “weight” of cardiac and general adiposity in predicting left ventricle morphology. Obesity. 2006;14:1679–84.CrossRefPubMed
19.
20.
Zurück zum Zitat Gordon S. Do macrophage innate immune receptors enhance atherogenesis? Dev Cell. 2003;5:666–8.CrossRefPubMed Gordon S. Do macrophage innate immune receptors enhance atherogenesis? Dev Cell. 2003;5:666–8.CrossRefPubMed
21.
Zurück zum Zitat Hofmann U, Knorr S, Vogel B, Weirather J, Frey A, Ertl G, et al. Interleukin-13 deficiency aggravates healing and remodeling in male mice after experimental myocardial infarction. Circ Heart Fail. 2014;7:822–30.CrossRefPubMed Hofmann U, Knorr S, Vogel B, Weirather J, Frey A, Ertl G, et al. Interleukin-13 deficiency aggravates healing and remodeling in male mice after experimental myocardial infarction. Circ Heart Fail. 2014;7:822–30.CrossRefPubMed
22.
Zurück zum Zitat Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes Implications for plaque rupture. Circulation. 1994;90:775–8.CrossRefPubMed Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes Implications for plaque rupture. Circulation. 1994;90:775–8.CrossRefPubMed
23.
Zurück zum Zitat Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:23844–50.CrossRef Libby P. Molecular bases of the acute coronary syndromes. Circulation. 1995;91:23844–50.CrossRef
24.
Zurück zum Zitat Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999;19:91–104.CrossRefPubMed Krishnaswamy G, Kelley J, Yerra L, Smith JK, Chi DS. Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res. 1999;19:91–104.CrossRefPubMed
25.
Zurück zum Zitat Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:78–86.CrossRef Greif M, Becker A, von Ziegler F, Lebherz C, Lehrke M, Broedl UC, et al. Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2009;29:78–86.CrossRef
26.
Zurück zum Zitat Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32.CrossRefPubMed Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990;15:827–32.CrossRefPubMed
27.
Zurück zum Zitat Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging Council on Clinical Cardiology. Circulation. 2006;114:1761–91.CrossRefPubMed Budoff MJ, Achenbach S, Blumenthal RS, Carr JJ, Goldin JG, Greenland P, et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging Council on Clinical Cardiology. Circulation. 2006;114:1761–91.CrossRefPubMed
28.
Zurück zum Zitat Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–45.CrossRefPubMed Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, et al. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med. 2008;358:1336–45.CrossRefPubMed
29.
Zurück zum Zitat Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as ‘‘low risk’’ based on Framingham risk score: the multiethnic study of atherosclerosis (MESA). Arch Intern Med. 2007;167:2437–42.CrossRefPubMed Lakoski SG, Greenland P, Wong ND, Schreiner PJ, Herrington DM, Kronmal RA, et al. Coronary artery calcium scores and risk for cardiovascular events in women classified as ‘‘low risk’’ based on Framingham risk score: the multiethnic study of atherosclerosis (MESA). Arch Intern Med. 2007;167:2437–42.CrossRefPubMed
30.
Zurück zum Zitat Zheng Y, Higuera FV, Zhou SK Fast and automatic heart isolation in 3d ct volumes: optimal shape initialization. IMLMI 2010: 84–91. Zheng Y, Higuera FV, Zhou SK Fast and automatic heart isolation in 3d ct volumes: optimal shape initialization. IMLMI 2010: 84–91.
31.
Zurück zum Zitat Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605–13.CrossRefPubMed Rosito GA, Massaro JM, Hoffmann U, Ruberg FL, Mahabadi AA, Vasan RS, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation. 2008;117:605–13.CrossRefPubMed
32.
Zurück zum Zitat Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, Szklo M, et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2009;90:499–504.CrossRefPubMedCentralPubMed Ding J, Hsu FC, Harris TB, Liu Y, Kritchevsky SB, Szklo M, et al. The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2009;90:499–504.CrossRefPubMedCentralPubMed
33.
Zurück zum Zitat Krueger K, Klocke R, Kloster J, Nikol S, Waltenberger J, Mooren FC. Activity of dialy living is associated with circulating CD34 +/KDR + cells and granulocyte colony-stimulating factor levels in pateints after myocardial infarction. J Appl Physiol. 2014;116:532–7.CrossRef Krueger K, Klocke R, Kloster J, Nikol S, Waltenberger J, Mooren FC. Activity of dialy living is associated with circulating CD34 +/KDR + cells and granulocyte colony-stimulating factor levels in pateints after myocardial infarction. J Appl Physiol. 2014;116:532–7.CrossRef
34.
Zurück zum Zitat Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31:969–79.CrossRefPubMed Ait-Oufella H, Taleb S, Mallat Z, Tedgui A. Recent advances on the role of cytokines in atherosclerosis. Arterioscler Thromb Vasc Biol. 2011;31:969–79.CrossRefPubMed
35.
Zurück zum Zitat Bruno S, Bussolati B, Scacciatella P, Marra S, Sanavio F, Tarella C, et al. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine. 2006;34:56–65.CrossRefPubMed Bruno S, Bussolati B, Scacciatella P, Marra S, Sanavio F, Tarella C, et al. Combined administration of G-CSF and GM-CSF stimulates monocyte-derived pro-angiogenic cells in patients with acute myocardial infarction. Cytokine. 2006;34:56–65.CrossRefPubMed
36.
Zurück zum Zitat Klinghammer L, Urschel K, Cicha I, Lewczuk P, Raaz-Schrauder D, Achenbach S, et al. Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis—influence on IP-10, TNF-α and MCP-1. Cytokine. 2013;62:290–6.CrossRefPubMed Klinghammer L, Urschel K, Cicha I, Lewczuk P, Raaz-Schrauder D, Achenbach S, et al. Impact of telmisartan on the inflammatory state in patients with coronary atherosclerosis—influence on IP-10, TNF-α and MCP-1. Cytokine. 2013;62:290–6.CrossRefPubMed
Metadaten
Titel
Association of systemic inflammation with epicardial fat and coronary artery calcification
verfasst von
Sören Gauss
Lutz Klinghammer
Alina Steinhoff
Dorette Raaz-Schrauder
Mohamed Marwan
Stephan Achenbach
Christoph D. Garlichs
Publikationsdatum
01.05.2015
Verlag
Springer Basel
Erschienen in
Inflammation Research / Ausgabe 5/2015
Print ISSN: 1023-3830
Elektronische ISSN: 1420-908X
DOI
https://doi.org/10.1007/s00011-015-0809-x

Weitere Artikel der Ausgabe 5/2015

Inflammation Research 5/2015 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.